BusinessMelinta Therapeutics’ Commercial Partner Eurofarma Laboratórios Submits Marketing Authorization Application for Delafloxacin in ArgentinaBy Nasdaq OMXFeb 20, 2018, 12:01 PM UTC
BusinessMelinta Therapeutics Provides for Distribution of Delafloxacin to 19 Countries via Extended Agreement with Eurofarma LaboratóriosBy Nasdaq OMXSep 26, 2017, 12:01 PM UTC